Showing results (181-190 of 332) with videos related to
Sort By:
Pageof 34
Cancer|June 11, 2009
Temozolomide concomitant and adjuvant to radiotherapy in elderly patients with glioblastoma: correlation with MGMT promoter methylation statusAlba A Brandes, Enrico Franceschi, Alicia Tosoni, et al.Cancer Treatment Reports|January 1, 1985
Peptichemio in pretreated patients with ovarian cancerA Paccagnella, F Tredese, L Salvagno, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 13, 2001
Temozolomide as a second-line systemic regimen in recurrent high-grade glioma: a phase II studyA A Brandes, M Ermani, U Basso, et al.Cancer|January 5, 2000
Chemotherapy in patients with recurrent and progressive central neurocytomaA A Brandes, P Amistà, M Gardiman, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 2004
Second-line chemotherapy with irinotecan plus carmustine in glioblastoma recurrent or progressive after first-line temozolomide chemotherapy: a phase II study of the Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO)Alba A Brandes, Alicia Tosoni, Umberto Basso, et al.Oncotarget|July 14, 2016
Sex-specific clinicopathological significance of novel (Frizzled-7) and established (MGMT, IDH1) biomarkers in glioblastomaSalveena Schiffgens, Ludwig Wilkens, Alba A Brandes, et al.Physical Chemistry Chemical Physics : PCCP|July 30, 2025
Rotational, vibrational, conformational and diastereomeric dimer cooling of aminoalcohols in soft supersonic expansions and the monohydrate of dimethylaminoethanolEaindra Lwin, Mathis J Gölz, Nils O B Lüttschwager, et al.Neurology|February 16, 2006
Is protracted low-dose temozolomide feasible in glioma patients?A Tosoni, G Cavallo, M Ermani, et al.Cancer|January 28, 2003
A prospective study on glioblastoma in the elderlyAlba A Brandes, Francesca Vastola, Umberto Basso, et al.British Journal of Cancer|October 7, 2006
Temozolomide 3 weeks on and 1 week off as first-line therapy for recurrent glioblastoma: phase II study from gruppo italiano cooperativo di neuro-oncologia (GICNO)A A Brandes, A Tosoni, G Cavallo, et al.Pageof 34